创新-话题@MedSci

#创新#

1015篇内容 | 8066人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1286089, encodeId=6beb12860892a, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=三个适应症连续获批！免疫创新药「乌帕替尼缓释片」开启银屑病关节炎靶向治疗新时代！, objectType=article, longId=298947, objectId=140429894ed8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=140429894ed8, replyNumber=0, likeNumber=81, createdTime=2022-02-18, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=140429894ed8, moduleTitle=三个适应症连续获批！免疫创新药「乌帕替尼缓释片」开启银屑病关节炎靶向治疗新时代！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=140429894ed8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286070, encodeId=b36612860e074, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=2022年2月15日简报：中国香港新增2052例本土确诊病例，创新高；苏州疫情病毒的初步分析结果是奥密克戎变异株；全球重症病例下降迅速, objectType=article, longId=295678, objectId=c1932956e843, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c1932956e843, replyNumber=0, likeNumber=56, createdTime=2022-02-16, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c1932956e843, moduleTitle=2022年2月15日简报：中国香港新增2052例本土确诊病例，创新高；苏州疫情病毒的初步分析结果是奥密克戎变异株；全球重症病例下降迅速, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c1932956e843)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286069, encodeId=60c41286069fe, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=术式创新！这种方法矫正鼻尖过度突出很有用, objectType=article, longId=295353, objectId=d31329535309, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d31329535309, replyNumber=0, likeNumber=67, createdTime=2022-02-11, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d31329535309, moduleTitle=术式创新！这种方法矫正鼻尖过度突出很有用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d31329535309)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286068, encodeId=93af128606877, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=高分SCI第一步：如何有创新地立题, objectType=article, longId=294411, objectId=cbf229441147, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cbf229441147, replyNumber=0, likeNumber=59, createdTime=2022-01-22, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cbf229441147, moduleTitle=高分SCI第一步：如何有创新地立题, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cbf229441147)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286067, encodeId=380b128606edd, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=活动预告｜科研系列直播课程：如何有创新地立题？, objectType=article, longId=294376, objectId=11322943e688, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11322943e688, replyNumber=0, likeNumber=34, createdTime=2022-01-22, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11322943e688, moduleTitle=活动预告｜科研系列直播课程：如何有创新地立题？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11322943e688)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286066, encodeId=16861286066ea, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=Clin Pharmacol Ther:Secukinumab治疗银屑病的创新儿科开发之路, objectType=article, longId=294274, objectId=fe2d2942e48c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe2d2942e48c, replyNumber=0, likeNumber=64, createdTime=2022-01-20, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe2d2942e48c, moduleTitle=Clin Pharmacol Ther:Secukinumab治疗银屑病的创新儿科开发之路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe2d2942e48c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286065, encodeId=1495128606533, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=2022年FDA有望批准的18款创新疗法, objectType=article, longId=294115, objectId=7e4a294115df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e4a294115df, replyNumber=0, likeNumber=0, createdTime=2022-01-18, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e4a294115df, moduleTitle=2022年FDA有望批准的18款创新疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e4a294115df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286064, encodeId=d64a1286064c5, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=2022年1月，FDA批准两款创新药，分别主治失眠和特异性皮炎, objectType=article, longId=294096, objectId=55c52940969e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55c52940969e, replyNumber=0, likeNumber=70, createdTime=2022-01-18, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55c52940969e, moduleTitle=2022年1月，FDA批准两款创新药，分别主治失眠和特异性皮炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55c52940969e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286063, encodeId=6516128606325, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=2022年1月11日简报：儿童更易感染奥密克戎，容易导致婴幼儿吼哮症；辉瑞CEO称3月底前或推出专门针对奥密克戎的新冠疫苗；印度感染人数创新高, objectType=article, longId=293817, objectId=d46629381e11, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d46629381e11, replyNumber=0, likeNumber=0, createdTime=2022-01-12, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d46629381e11, moduleTitle=2022年1月11日简报：儿童更易感染奥密克戎，容易导致婴幼儿吼哮症；辉瑞CEO称3月底前或推出专门针对奥密克戎的新冠疫苗；印度感染人数创新高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d46629381e11)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286062, encodeId=89fa12860621b, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=NMPA：2021年获批准上市的创新药, objectType=article, longId=293072, objectId=72322930e2eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72322930e2eb, replyNumber=0, likeNumber=86, createdTime=2021-12-31, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72322930e2eb, moduleTitle=NMPA：2021年获批准上市的创新药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72322930e2eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286060, encodeId=86871286060a3, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=直播：脑认知与神经调控融合创新论坛-蓝手帕公益项目, objectType=article, longId=292590, objectId=2fe82925908b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fe82925908b, replyNumber=0, likeNumber=28, createdTime=2021-12-24, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fe82925908b, moduleTitle=直播：脑认知与神经调控融合创新论坛-蓝手帕公益项目, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2fe82925908b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286059, encodeId=2b39128605945, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=2021 CCHC：陈义汉院士：心脏病学原始创新任重道远, objectType=article, longId=292491, objectId=d8e729249120, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8e729249120, replyNumber=0, likeNumber=83, createdTime=2021-12-23, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8e729249120, moduleTitle=2021 CCHC：陈义汉院士：心脏病学原始创新任重道远, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8e729249120)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286058, encodeId=ca8f1286058cc, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=2021 CCHC：滕皋军院士：外周介入创新的探索与实践, objectType=article, longId=292489, objectId=907d29248939, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=907d29248939, replyNumber=0, likeNumber=87, createdTime=2021-12-23, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=907d29248939, moduleTitle=2021 CCHC：滕皋军院士：外周介入创新的探索与实践, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=907d29248939)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286061, encodeId=fb431286061a4, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=术式创新！肋软骨弹簧移植矫正成人唇裂鼻畸形, objectType=article, longId=292424, objectId=c8ac29242464, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c8ac29242464, replyNumber=0, likeNumber=69, createdTime=2021-12-22, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c8ac29242464, moduleTitle=术式创新！肋软骨弹簧移植矫正成人唇裂鼻畸形, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c8ac29242464)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286054, encodeId=3789128605449, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=2021年11月27日简报：张文宏解读上海精准防疫；Molnupiravir疗效仅降低重症和死亡约30%；新突变株B.1.1.529引发全球紧张；韩国与新冠共存后，新冠重症病例创新高；, objectType=article, longId=221161, objectId=eff72211617f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eff72211617f, replyNumber=0, likeNumber=0, createdTime=2021-11-28, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eff72211617f, moduleTitle=2021年11月27日简报：张文宏解读上海精准防疫；Molnupiravir疗效仅降低重症和死亡约30%；新突变株B.1.1.529引发全球紧张；韩国与新冠共存后，新冠重症病例创新高；, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eff72211617f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286053, encodeId=a9651286053bc, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=2021年11月18日简报：多国新增病例创新高，但全球死亡人数平稳；多国死亡人数中位年龄为80岁左右；我国全力推进老年人新冠疫苗应接尽接, objectType=article, longId=220559, objectId=dda322055939, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dda322055939, replyNumber=0, likeNumber=58, createdTime=2021-11-19, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dda322055939, moduleTitle=2021年11月18日简报：多国新增病例创新高，但全球死亡人数平稳；多国死亡人数中位年龄为80岁左右；我国全力推进老年人新冠疫苗应接尽接, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dda322055939)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286052, encodeId=de4d12860522b, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=2021ATS BEAR Cage 创新奖：微生物组移植治疗肺动脉高压, objectType=article, longId=220229, objectId=06ea220229b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06ea220229b3, replyNumber=0, likeNumber=75, createdTime=2021-11-13, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06ea220229b3, moduleTitle=2021ATS BEAR Cage 创新奖：微生物组移植治疗肺动脉高压, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=06ea220229b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286049, encodeId=ce85128604927, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=6. 探索原始创新思路, objectType=article, longId=220089, objectId=2e4e220089cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e4e220089cd, replyNumber=0, likeNumber=54, createdTime=2021-11-12, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e4e220089cd, moduleTitle=6. 探索原始创新思路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e4e220089cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286048, encodeId=10ab1286048d6, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=5. 探索原始创新思路, objectType=article, longId=220087, objectId=4fd822008e07, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4fd822008e07, replyNumber=0, likeNumber=51, createdTime=2021-11-12, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4fd822008e07, moduleTitle=5. 探索原始创新思路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4fd822008e07)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286051, encodeId=25851286051f9, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=4. 原始创新的特点, objectType=article, longId=220082, objectId=c908220082f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c908220082f1, replyNumber=0, likeNumber=50, createdTime=2021-11-12, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c908220082f1, moduleTitle=4. 原始创新的特点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c908220082f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

创新

2020-05-29

lilianxiang (审核中...)

前往app查看评论内容

#创新#

三个适应症连续获批！免疫创新药「乌帕替尼缓释片」开启银屑病关节炎靶向治疗新时代！

2022-02-18

lilianxiang (审核中...)

前往app查看评论内容

#创新#

2022年2月15日简报：中国香港新增2052例本土确诊病例，创新高；苏州疫情病毒的初步分析结果是奥密克戎变异株；全球重症病例下降迅速

2022-02-16

lilianxiang (审核中...)

前往app查看评论内容

#创新#

术式创新！这种方法矫正鼻尖过度突出很有用

2022-02-11

lilianxiang (审核中...)

前往app查看评论内容

#创新#

高分SCI第一步：如何有创新地立题

2022-01-22

lilianxiang (审核中...)

前往app查看评论内容

#创新#

活动预告｜科研系列直播课程：如何有创新地立题？

2022-01-22

lilianxiang (审核中...)

前往app查看评论内容

#创新#

Clin Pharmacol Ther:Secukinumab治疗银屑病的创新儿科开发之路

2022-01-20

lilianxiang (审核中...)

前往app查看评论内容

#创新#

2022年FDA有望批准的18款创新疗法

2022-01-18

lilianxiang (审核中...)

前往app查看评论内容

#创新#

2022年1月，FDA批准两款创新药，分别主治失眠和特异性皮炎

2022-01-18

lilianxiang (审核中...)

前往app查看评论内容

#创新#

2022年1月11日简报：儿童更易感染奥密克戎，容易导致婴幼儿吼哮症；辉瑞CEO称3月底前或推出专门针对奥密克戎的新冠疫苗；印度感染人数创新高

2022-01-12

lilianxiang (审核中...)

前往app查看评论内容

#创新#

NMPA：2021年获批准上市的创新药

2021-12-31

lilianxiang (审核中...)

前往app查看评论内容

#创新#

直播：脑认知与神经调控融合创新论坛-蓝手帕公益项目

2021-12-24

lilianxiang (审核中...)

前往app查看评论内容

#创新#

2021 CCHC：陈义汉院士：心脏病学原始创新任重道远

2021-12-23

lilianxiang (审核中...)

前往app查看评论内容

#创新#

2021 CCHC：滕皋军院士：外周介入创新的探索与实践

2021-12-23

lilianxiang (审核中...)

前往app查看评论内容

#创新#

术式创新！肋软骨弹簧移植矫正成人唇裂鼻畸形

2021-12-22

lilianxiang (审核中...)

前往app查看评论内容

#创新#

2021年11月27日简报：张文宏解读上海精准防疫；Molnupiravir疗效仅降低重症和死亡约30%；新突变株B.1.1.529引发全球紧张；韩国与新冠共存后，新冠重症病例创新高；

2021-11-28

lilianxiang (审核中...)

前往app查看评论内容

#创新#

2021年11月18日简报：多国新增病例创新高，但全球死亡人数平稳；多国死亡人数中位年龄为80岁左右；我国全力推进老年人新冠疫苗应接尽接

2021-11-19

lilianxiang (审核中...)

前往app查看评论内容

#创新#

2021ATS BEAR Cage 创新奖：微生物组移植治疗肺动脉高压

2021-11-13

lilianxiang (审核中...)

前往app查看评论内容

#创新#

6. 探索原始创新思路

2021-11-12

lilianxiang (审核中...)

前往app查看评论内容

#创新#

5. 探索原始创新思路

2021-11-12

lilianxiang (审核中...)

前往app查看评论内容

#创新#

4. 原始创新的特点

2021-11-12

科室
- - 订阅+
  - 更多科室
工具
服务